Oracle Investment Management Inc Biocryst Pharmaceuticals Inc Transaction History

Oracle Investment Management Inc

$43.2 Million
Q3 2024

A detailed history of Oracle Investment Management Inc transactions in Biocryst Pharmaceuticals Inc stock. As of the latest transaction made, Oracle Investment Management Inc holds 535,558 shares of BCRX stock, worth $4.07 Million. This represents 9.42% of its overall portfolio holdings.

Number of Shares

535,558

Previous 535,558 -0.0%

Holding current value

$4.07 Million

Previous $3.31 Million 23.0%

% of portfolio

9.42%

Previous 8.72%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	SELL	$4.98 - $6.77 $99,420 - $135,156	-19,964 Reduced 3.59%	535,558 $3.21 Million
Q1 2023 May 15, 2023	SELL	$7.94 - $11.84 $235,595 - $351,316	-29,672 Reduced 5.07%	555,522 $4.63 Million
Q4 2022 Feb 14, 2023	SELL	$10.5 - $14.2 $525,000 - $710,000	-50,000 Reduced 7.87%	585,194 $6.72 Million
Q3 2022 Nov 14, 2022	BUY	$10.79 - $14.81 $336,648 - $462,072	31,200 Added 5.17%	635,194 $8 Million
Q2 2022 Aug 15, 2022	SELL	$7.89 - $17.88 $8.81 Million - $20 Million	-1,116,739 Reduced 64.9%	603,994 $6.39 Million
Q1 2022 May 16, 2022	BUY	$11.56 - $19.76 $578,000 - $988,000	50,000 Added 2.99%	1,720,733 $28 Million
Q4 2021 Feb 14, 2022	SELL	$11.18 - $15.46 $2.8 Million - $3.87 Million	-250,000 Reduced 13.02%	1,670,733 $23.1 Million
Q2 2021 Aug 16, 2021	SELL	$9.5 - $17.24 $4.25 Million - $7.71 Million	-446,937 Reduced 18.88%	1,920,733 $30.4 Million
Q1 2021 May 17, 2021	SELL	$7.37 - $13.61 $4.52 Million - $8.35 Million	-613,200 Reduced 20.57%	2,367,670 $24.1 Million
Q4 2020 Feb 16, 2021	BUY	$3.37 - $8.61 $1.53 Million - $3.92 Million	455,013 Added 18.01%	2,980,870 $22.2 Million
Q3 2020 Nov 16, 2020	BUY	$3.43 - $5.53 $1.8 Million - $2.91 Million	525,857 Added 26.29%	2,525,857 $8.68 Million
Q2 2020 Aug 14, 2020	BUY	$1.9 - $5.61 $3.8 Million - $11.2 Million	2,000,000 New	2,000,000 $9.53 Million

Others Institutions Holding BCRX

# of Institutions

279

Shares Held

172M

Call Options Held

625K

Put Options Held

739K

View Full List

About BIOCRYST PHARMACEUTICALS INC

Ticker BCRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,944,992
Market Cap $1.41B
Description
BioCryst Pharmaceuticals, Inc., a biotechnology company, discovers novel, oral, and small-molecule medicines. The company markets peramivir injection, an intravenous neuraminidase inhibitor for the treatment of acute uncomplicated influenza under the RAPIVAB, RAPIACTA, and PERAMIFLU names; and ORLADEYO, an oral serine protease inhibitor to treat...

More about BCRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Oracle Investment Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Oracle Investment Management Inc with notifications on news.

Account

Oracle Investment Management Inc Biocryst Pharmaceuticals Inc Transaction History